<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>m/m19, f/ğŸ¦€, f/ğŸ•¶ï¸, a/Intervention, a/Intervention on</title><link>https://test.vincentweber.net/tags/m/m19-f/-f/%EF%B8%8F-a/Intervention-a/Intervention/</link><description>Recent content in m/m19, f/ğŸ¦€, f/ğŸ•¶ï¸, a/Intervention, a/Intervention on</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><atom:link href="https://test.vincentweber.net/tags/m/m19-f/-f/%EF%B8%8F-a/Intervention-a/Intervention/index.xml" rel="self" type="application/rss+xml"/><item><title/><link>https://test.vincentweber.net/Medizin/Theranostik/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://test.vincentweber.net/Medizin/Theranostik/</guid><description>Theranostik VerknÃ¼pfung von Diagnostik und Therapie i.d. [[Nuklearmedizin]]
Gleicher Ligand, aber unterschiedliches Radionuklid fÃ¼r Diagnostik/Therapie Beispiele [[SchilddrÃ¼se]]: I-123 + I-131 [[Neuroblastom]]: I-123-MIBG + I-131-MIBG [[Neuroendokrine Tumoren]]: Ga-68-DOTATOC + Lu-177-DOTATOC ==[[Prostata-Ca]]: Ga68-PSMA + Lu-177-PSMA==</description></item></channel></rss>